Avidity Partners Management LP Revolution Medicines, Inc. Transaction History
Avidity Partners Management LP
- $370 Million
- Q2 2025
A detailed history of Avidity Partners Management LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 228,600 shares of RVMD stock, worth $10.4 Million. This represents 2.27% of its overall portfolio holdings.
Number of Shares
228,600
Previous 213,000
7.32%
Holding current value
$10.4 Million
Previous $7.53 Million
11.67%
% of portfolio
2.27%
Previous 1.69%
Shares
13 transactions
Others Institutions Holding RVMD
# of Institutions
333Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$720 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$655 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$613 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$484 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$469 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.01B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...